Compare MDCX & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MDCX | PMAX |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 2.7M |
| IPO Year | 2025 | 2024 |
| Metric | MDCX | PMAX |
|---|---|---|
| Price | $0.16 | $0.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 5.5M | 99.4K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $0.20 |
| 52 Week High | $2.78 | $5.20 |
| Indicator | MDCX | PMAX |
|---|---|---|
| Relative Strength Index (RSI) | 31.76 | 42.71 |
| Support Level | $0.15 | $0.75 |
| Resistance Level | $0.36 | $1.38 |
| Average True Range (ATR) | 0.02 | 0.11 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 26.32 | 33.91 |
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
Powell Max Ltd operates as a financial communications platform supporting listed companies and IPO applicants throughout the capital markets lifecycle. Substantially all of the company's revenue is generated from Hong Kong. The group focused on supporting the disclosure, reporting, and transaction needs of corporate clients and their advisors. Its mission is to combine industry knowledge, execution capabilities, and a commitment to service to deliver accurate, timely, and reliable solutions for customers.